about
Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in ChildrenPharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adultsChronic Renal Transplant Rejection and Possible Anti-Proliferative Drug TargetsInflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological TreatmentsBeyond cancer treatment - a review of total lymphoid irradiation for heart and lung transplant recipients.Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug TherapyReconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomesNUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicityManaging refractory Crohn's disease: challenges and solutionsTargeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.Risk factors for symptomatic osteonecrosis in childhood ALL: A retrospective study of a Slovenian pediatric ALL population between 1970 and 2004.Adipose mesenchymal stromal cell function is not affected by methotrexate and azathioprine.New molecular targets for the treatment of sarcoidosis.Medical management of crohn disease.Mesenteric panniculitis: an update.Immunology of idiopathic nephrotic syndrome.Current and Emerging Therapies for Lupus Nephritis.Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion.From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis.Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches.Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease.Deciphering function of new gonococcal vaccine antigens using phenotypic microarrays.Pharmacologic Treatment of Noninfectious Uveitis.Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis.Comparative genomics of an endophytic Pseudomonas putida isolated from mango orchard.Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins.Circulating NK cells and their subsets in Behçet's disease.Increased Telomere Attrition After Renal Transplantation-Impact of Antimetabolite Therapy.Hepatic perturbations provoked by azathioprine: a paradigm to rationalize the cytoprotective potential of Ficus hispida Linn.Utility of azathioprine metabolite measurements in post-transplant recurrent autoimmune and immune-mediated hepatitis.Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability.Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.Potential immunotherapies for sarcoidosis.Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and anti-leukemic efficacy.Folic Acid and Grape Seed Extract Prevent Azathioprine-induced Fetal Malformations and Renal Toxicity in Rats.Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish.Emerging treatment options for the management of pemphigus vulgaris.The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation.
P2860
Q26747770-DF048BD8-14A2-4D5B-8C32-84E6BDD9B3EBQ26768280-F41FF317-6805-4507-A334-FD40BF978EB7Q26775103-2FD60EB6-0ADD-4202-A1D2-5763403AD37CQ26785537-486E7A4E-4283-4C89-A39A-A6367FF2F402Q26801075-981021F3-31B5-48EB-B3DE-55C95BD3FDBAQ28073100-0A3465AE-7349-4400-9B5B-0B0FE3ED4E00Q28080994-8D29D850-18E5-4245-99FE-EC89FDD0DFA4Q28115755-2AA69CB2-546A-4554-B545-7656DEB74F46Q35460367-927E6EA6-0EF9-4119-BD85-E4F9E4268AAEQ35862596-7BD0E8FE-0C0F-4C7E-B6C9-2FAFAFCAED6BQ37106645-A6B919C2-8F33-4669-B232-677EDC5399D0Q37406683-D5BB2CC8-9E55-4847-A981-74929394B6C0Q37494750-4ED23236-9D75-47B0-82DB-C05BF9B8B260Q38179378-E51CC494-E0FA-4BF3-926A-014543B3BBC1Q38249074-04A35E4C-E9BF-40FC-8210-84DC320888E4Q38815449-78654BE8-F95E-4264-B827-6C8EB5932B53Q38855495-4A5C9B2F-C89B-407E-B253-ED020A7E6D7BQ38930837-9F0EDFDF-FADE-4FF4-8EFB-1152D83D264EQ38946338-A0EB3000-9F17-4DEC-878D-47A4BA625845Q39032639-9B757DF5-CADC-48E2-92BA-715D8E8EED3BQ39426072-7171BB60-EDF4-4492-8F94-FBFE8D17037FQ39684886-DCFDF5DA-1126-4A56-B3A3-A9F05AA76418Q40166275-6725D00B-E78E-4934-AE77-E5311C52E9E6Q40450258-B670EEA8-6587-4990-A1A3-8D0DA2DACCE6Q40487999-EF252FC0-3452-4DFB-85DE-779CA3BF1D13Q40975277-D4DE732B-D56C-46DD-AC24-7975812EFFCFQ42052555-37DCF8F0-A424-4809-B6FD-897F61299EF7Q42097602-6968A969-B5B7-4CB0-AE92-FEE77130D93DQ42356947-855B5E72-A757-4524-8480-C5B366E0A6E3Q43271964-76C35707-A621-4824-94C8-716EB5E4B5F2Q45186685-543F0F89-2B08-454C-A48A-CEA58DDD68FEQ46758099-39D11910-DFEE-4C64-BD61-5287146C3ADBQ47619805-E3FAA03B-5DFF-4DA0-8D48-926EF8FB1251Q48191847-AF9C0B7F-77CC-4F70-BB93-5A1301DF23E3Q50072080-133A8920-F905-48CD-9E70-FF74598D0AC7Q51735726-0D64072F-4E27-452D-8F58-9707DFA67A79Q53753115-103E1328-41E8-4E5F-82C8-3D8CBA28D32BQ54246706-5B8F658D-2711-4E21-8EE1-02E4009C2F31Q55433740-5213DAAA-C573-4A12-8E66-6A62116E65F1Q55692477-0AF56025-9F8A-4C52-BCFD-4C9618A159AE
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Azathioprine: old drug, new actions.
@ast
Azathioprine: old drug, new actions.
@en
Azathioprine: old drug, new actions.
@nl
type
label
Azathioprine: old drug, new actions.
@ast
Azathioprine: old drug, new actions.
@en
Azathioprine: old drug, new actions.
@nl
prefLabel
Azathioprine: old drug, new actions.
@ast
Azathioprine: old drug, new actions.
@en
Azathioprine: old drug, new actions.
@nl
P2860
P356
P1476
Azathioprine: old drug, new actions.
@en
P2093
Gary A Koretzky
Jonathan S Maltzman
P2860
P304
P356
10.1172/JCI200318384
P407
P577
2003-04-01T00:00:00Z